6533b7d1fe1ef96bd125cea0

RESEARCH PRODUCT

Early detection of gastric cancer beyond endoscopy - new methods

Mārcis LejaAija Line

subject

0301 basic medicinemedicine.diagnostic_testbusiness.industryGastroenterologyEarly detectionCancerEndoscopymedicine.diseaseSurvival AnalysisExtracellular vesiclesEndoscopy03 medical and health sciences030104 developmental biology0302 clinical medicineStomach Neoplasms030220 oncology & carcinogenesismicroRNACancer researchHumansMedicineTherapy monitoringbusinessEarly Detection of Cancer

description

Early detection of gastric cancer is remaining a challenge. This review summarizes current knowledge on non-invasive methods that could be used for the purpose. The role of traditional cancer markers such as CEA, CA 72-4, CA 19-9, CA 15-3, and CA 12-5 lies mainly in therapy monitoring than early detection. Most extensive studied biomarkers (pepsinogens, ABC method) are aiming at the detection of precancerous lesions with modest sensitivity for cancer. Tests based on the detection of cancer-specific methylation patterns (PanSeer), circulating proteins and mutations in circulating tumour DNA (CancerSEEK), as well as miRNA panels have demonstrated promising results bringing those closer to practice. More extensive research is required before tests based on the detection of circulating tumour cells, extracellular vesicles and cell-free RNA could reach the practice. Detection of volatile organic compounds in the human breath is a promising development; sensor technologies for this purpose could be very attractive in screening settings.

https://doi.org/10.1016/j.bpg.2021.101731